Stocks
Asensus Surgical Financial Statements (ASXC) |
||||||||||
| Asensus Surgicalsmart-lab.ru | % | 2022 | 2022 | 2023 | 2023 | LTM ? | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.06.2022 | 31.12.2022 | 02.03.2023 | 21.03.2024 | 29.04.2024 | 13.08.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 7.09 | 7.09 | 8.58 | 8.58 | 14.2 | ||||
| Operating Income, bln rub | -75.7 | -75.7 | -78.1 | -78.1 | -66.7 | |||||
| EBITDA, bln rub | ? | -63.8 | -64.3 | -74.4 | -74.4 | -62.8 | ||||
| Net profit, bln rub | ? | -75.6 | -75.6 | -78.4 | -78.4 | -82.7 | ||||
| OCF, bln rub | ? | -58.9 | -58.9 | -63.6 | -63.6 | -55.0 | ||||
| CAPEX, bln rub | ? | 1.28 | 1.28 | 0.561 | 0.561 | 0.257 | ||||
| FCF, bln rub | ? | -60.2 | -60.2 | -64.2 | -64.2 | -55.2 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| OPEX, bln rub | 71.9 | 71.6 | 73.1 | 73.1 | 66.2 | |||||
| Cost of production, bln rub | 10.9 | 10.9 | 13.6 | 13.6 | 14.7 | |||||
| R&D, bln rub | 28.9 | 28.9 | 37.0 | 37.0 | 32.9 | |||||
| Interest expenses, bln rub | 0.410 | 0.410 | 0.000 | 0.000 | 0.499 | |||||
| Assets, bln rub | 147.4 | 116.1 | 116.1 | 60.5 | 60.5 | 38.5 | ||||
| Net Assets, bln rub | ? | 131.4 | 99.6 | 99.6 | 33.4 | 33.4 | -11.3 | |||
| Debt, bln rub | 5.19 | 5.54 | 5.54 | 5.68 | 5.68 | 20.4 | ||||
| Cash, bln rub | 94.2 | 70.5 | 70.5 | 21.1 | 21.1 | 7.78 | ||||
| Net debt, bln rub | -89.0 | -65.0 | -65.0 | -15.4 | -15.4 | 12.7 | ||||
| Ordinary share price, rub | 0.400 | 0.347 | 0.347 | 0.319 | 0.319 | |||||
| Number of ordinary shares, mln | 236.5 | 236.5 | 249.7 | 249.7 | 272.3 | |||||
| Market cap, bln rub | 0 | 82 | 82 | 80 | 80 | 0 | ||||
| EV, bln rub | ? | -89 | 17 | 17 | 64 | 64 | 13 | |||
| Book value, bln rub | 131 | 100 | 98 | 32 | 32 | -11 | ||||
| EPS, rub | ? | -0.32 | -0.32 | -0.31 | -0.31 | -0.30 | ||||
| FCF/share, rub | -0.25 | -0.25 | -0.26 | -0.26 | -0.20 | |||||
| BV/share, rub | 0.42 | 0.41 | 0.13 | 0.13 | -0.04 | |||||
| EBITDA margin, % | ? | -899.6% | -907.1% | -867.4% | -867.4% | -442.4% | ||||
| Net margin, % | ? | -1 066% | -1 066% | -914.5% | -914.5% | -582.8% | ||||
| FCF yield, % | ? | 0.00% | -73.4% | -73.4% | -80.6% | -80.6% | ||||
| ROE, % | ? | 0.00% | -75.8% | -75.8% | -234.7% | -234.7% | 730.3% | |||
| ROA, % | ? | 0.00% | -65.1% | -65.1% | -129.6% | -129.6% | -214.8% | |||
| P/E | ? | -1.09 | -1.09 | -1.02 | -1.02 | 0 | ||||
| P/FCF | -1.36 | -1.36 | -1.24 | -1.24 | 0 | |||||
| P/S | ? | 11.6 | 11.6 | 9.28 | 9.28 | 0 | ||||
| P/BV | ? | 0.00 | 0.82 | 0.84 | 2.47 | 2.47 | 0 | |||
| EV/EBITDA | ? | -0.27 | -0.27 | -0.86 | -0.86 | -0.20 | ||||
| Debt/EBITDA | 1.02 | 1.01 | 0.21 | 0.21 | -0.20 | |||||
| R&D/CAPEX, % | 2 263% | 2 263% | 6 599% | 6 599% | 12 821% | |||||
| CAPEX/Revenue, % | 18.0% | 18.0% | 6.54% | 6.54% | 1.81% | |||||
| Asensus Surgical shareholders | ||||||||||
